Literature DB >> 11791176

Functional roles of Akt signaling in mouse skin tumorigenesis.

Carmen Segrelles1, Sergio Ruiz, Paloma Perez, Cristina Murga, Mirentxu Santos, Irina V Budunova, Jesús Martínez, Fernando Larcher, Thomas J Slaga, J Silvio Gutkind, Jose L Jorcano, Jesús M Paramio.   

Abstract

The mouse skin carcinogenesis protocol is a unique model for understanding the molecular events leading to oncogenic transformation. Mutations in the Ha-ras gene, and the presence of functional cyclin D1 and the EGF receptor, have proven to be important in this system. However, the signal transduction pathways connecting these elements during mouse skin carcinogenesis are poorly understood. This paper studies the relevance of the Akt and ERK pathways in the different stages of chemically induced mouse skin tumors. Akt activity increases throughout the entire process, and its early activation is detected prior to increased cyclin D1 expression. ERK activity rises only during the later stages of malignant conversion. The observed early increase in Akt activity appears to be due to raised PI-3K activity. Other factors acting on Akt such as ILK activation and decreased PTEN phosphatase activity appear to be involved at the conversion stage. To further confirm the involvement of Akt in this process, PB keratinocytes were transfected with Akt and subsequently injected into nude mice. The expression of Akt accelerates tumorigenesis and contributes to increased malignancy of these keratinocytes as demonstrated by the rate of appearance, the growth and the histological characteristics of the tumors. Collectively, these data provide evidence that Akt activation is one of the key elements during the different steps of mouse skin tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11791176     DOI: 10.1038/sj.onc.1205032

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  56 in total

Review 1.  Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.

Authors:  Okkyung Rho; Dae Joon Kim; Karou Kiguchi; John Digiovanni
Journal:  Mol Carcinog       Date:  2010-07-20       Impact factor: 4.784

Review 2.  Modulation of protein kinase signaling cascades by palytoxin.

Authors:  Elizabeth V Wattenberg
Journal:  Toxicon       Date:  2010-11-09       Impact factor: 3.033

3.  LKB1 deficiency sensitizes mice to carcinogen-induced tumorigenesis.

Authors:  Sushma Gurumurthy; Aram F Hezel; Ergun Sahin; Justin H Berger; Marcus W Bosenberg; Nabeel Bardeesy
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

4.  Differential Role of the RasGEFs Sos1 and Sos2 in Mouse Skin Homeostasis and Carcinogenesis.

Authors:  Pilar Liceras-Boillos; David Jimeno; Rósula García-Navas; L Francisco Lorenzo-Martín; Mauricio Menacho-Marquez; Carmen Segrelles; Carmela Gómez; Nuria Calzada; Rocío Fuentes-Mateos; Jesús M Paramio; Xosé R Bustelo; Fernando C Baltanás; Eugenio Santos
Journal:  Mol Cell Biol       Date:  2018-07-30       Impact factor: 4.272

5.  Rapamycin is a potent inhibitor of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.

Authors:  L Allyson Checkley; Okkyung Rho; Tricia Moore; Steve Hursting; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2011-07

6.  Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma.

Authors:  Marta Moral; Carmen Segrelles; M Fernanda Lara; Ana Belén Martínez-Cruz; Corina Lorz; Mirentxu Santos; Ramón García-Escudero; Jerry Lu; Kaoru Kiguchi; Agueda Buitrago; Clotilde Costa; Cristina Saiz; Jose L Rodriguez-Peralto; Francisco J Martinez-Tello; Maria Rodriguez-Pinilla; Montserrat Sanchez-Cespedes; Marina Garín; Teresa Grande; Ana Bravo; John DiGiovanni; Jesús M Paramio
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

7.  Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation.

Authors:  Karin List; Roman Szabo; Alfredo Molinolo; Virote Sriuranpong; Vivien Redeye; Tricia Murdock; Beth Burke; Boye S Nielsen; J Silvio Gutkind; Thomas H Bugge
Journal:  Genes Dev       Date:  2005-08-15       Impact factor: 11.361

Review 8.  Lessons learned from next-generation sequencing in head and neck cancer.

Authors:  Myriam Loyo; Ryan J Li; Chetan Bettegowda; Curtis R Pickering; Mitchell J Frederick; Jeffrey N Myers; Nishant Agrawal
Journal:  Head Neck       Date:  2012-08-21       Impact factor: 3.147

9.  A retroinhibition approach reveals a tumor cell-autonomous response to rapamycin in head and neck cancer.

Authors:  Panomwat Amornphimoltham; Vyomesh Patel; Kantima Leelahavanichkul; Robert T Abraham; J Silvio Gutkind
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

10.  Constitutively active Akt induces ectodermal defects and impaired bone morphogenetic protein signaling.

Authors:  Carmen Segrelles; Marta Moral; Corina Lorz; Mirentxu Santos; Jerry Lu; José Luis Cascallana; M Fernanda Lara; Steve Carbajal; Ana Belén Martínez-Cruz; Ramón García-Escudero; Linda Beltran; José C Segovia; Ana Bravo; John DiGiovanni; Jesús M Paramio
Journal:  Mol Biol Cell       Date:  2007-10-24       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.